Riley Fadden
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 15
- Colorectal Cancer Treatments and Studies 5
- CAR-T cell therapy research 3
- Cancer Diagnosis and Treatment 2
- Neurology top 10%
- Genetics top 10%
-
- Immunotherapy and Immune Responses 2
-
- Melanoma and MAPK Pathways 4
-
- Renal cell carcinoma treatment 2
-
- Drug-Induced Adverse Reactions 2
- Co-authors
- Ryan J. SullivanDonald P. LawrenceAlexander T. FajeLisa B. NachtigallAnne KlibanskiNicholas A. TritosJustine V. CohenKrista M. Rubin
- Journals
- Journal of Clinical Oncology (6 papers)Journal for ImmunoTherapy of Cancer (4 papers)Journal of the American Academy of Dermatology (1 paper)
- Partner nations
- United StatesChinaEthiopia
In The Last Decade
Riley Fadden
18 papers receiving 900 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Oncology 714
- Neurology 191
- Genetics 85
- Epidemiology 237
- Immunology 143
Countries citing papers authored by Riley Fadden
This map shows the geographic impact of Riley Fadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riley Fadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riley Fadden more than expected).
Fields of papers citing papers by Riley Fadden
This network shows the impact of papers produced by Riley Fadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riley Fadden. The network helps show where Riley Fadden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Riley Fadden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 23 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 8 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 10 | |
| 11 | 2019 | 75 | |
| 12 | 2019 | 3 | |
| 13 | 2019 | 2 | |
| 14 | High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanomabreakdown → | 2018 | 348 |
| 15 | 2018 | 2 | |
| 16 | 2017 | 0 | |
| 17 | 2015 | 2 | |
| 18 | 2014 | 363 | |
| 19 | Large hiatal hernias, anemia, and linear gastric erosion: studies of etiology and medical therapy. | 1992 | 39 |
About Riley Fadden
Riley Fadden is a scholar working on Oncology, Gastroenterology and Speech and Hearing, having authored 19 papers that have together received 918 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (15 papers), Colorectal Cancer Treatments and Studies (5 papers), Melanoma and MAPK Pathways (4 papers), CAR-T cell therapy research (3 papers), Renal cell carcinoma treatment (2 papers), Drug-Induced Adverse Reactions (2 papers), Cancer Diagnosis and Treatment (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (714 citations), Neurology (191 citations) and Genetics (85 citations). Riley Fadden has collaborated with scholars based in United States, China and Ethiopia. Frequent co-authors include Ryan J. Sullivan, Donald P. Lawrence, Alexander T. Faje, Lisa B. Nachtigall, Anne Klibanski, Nicholas A. Tritos, Justine V. Cohen, Krista M. Rubin, Keith T. Flaherty and Christine Freedman. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Journal of the American Academy of Dermatology, Cancer and Kidney International Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.